UK markets closed

Molecular Partners AG (MOLN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
3.2500+0.0800 (+2.52%)
At close: 05:31PM CEST
Currency in CHF

Valuation measures4

Market cap (intra-day) 104.19M
Enterprise value -79.04M
Trailing P/E N/A
Forward P/E 153.85
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.76
Price/book (mrq)0.59
Enterprise value/revenue -11.23
Enterprise value/EBITDA 1.33

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3-47.17%
S&P500 52-week change 325.38%
52-week high 36.1800
52-week low 33.0400
50-day moving average 33.5145
200-day moving average 33.9679

Share statistics

Avg vol (3-month) 312.93k
Avg vol (10-day) 314.31k
Shares outstanding 532.87M
Implied shares outstanding 632.87M
Float 817.14M
% held by insiders 19.19%
% held by institutions 139.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,613.18%

Management effectiveness

Return on assets (ttm)-16.58%
Return on equity (ttm)-30.12%

Income statement

Revenue (ttm)7.04M
Revenue per share (ttm)0.22
Quarterly revenue growth (yoy)-61.70%
Gross profit (ttm)N/A
EBITDA -60.18M
Net income avi to common (ttm)-61.98M
Diluted EPS (ttm)-1.8900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)186.89M
Total cash per share (mrq)5.69
Total debt (mrq)3.65M
Total debt/equity (mrq)2.07%
Current ratio (mrq)13.35
Book value per share (mrq)5.37

Cash flow statement

Operating cash flow (ttm)-59.01M
Levered free cash flow (ttm)-34.2M